Continuous Glucose Monitor for Gestational Diabetes Diagnosis Study (CGM)
Principal Investigator: Nasim Sobhani, MD
Researchers at UCSF are interested in investigating a new method of gestational diabetes diagnosis. This new method involves wearing a medical device known as a Continuous Glucose Monitor (CGM). Participation involves wearing a Dexcom G6 CGM for 10 days prior to their scheduled oral glucose tolerance test and completing surveys.
Research Coordinators:
Cyvanah Byrd-Eley 
Eniola Owoyele
Maternal Factors Regulating Metabolism and Diabetes Study
Principal Investigators: Michael German, MD; Chester Chamberlain, PhD
The purpose of this study is to better understand gestational diabetes and its relation to a biomarker called placental exosome, found in blood samples of pregnant patients. Participants will donate 2 test tubes of blood at their prenatal visit.
Research Coordinators:
Cyvanah Byrd-Eley Eniola Owoyele
Comparative effectiveness of two aspirin doses for prevention of hypertensive disorders of pregnancy (ASPIRIN)
Principal Investigators: Mary Norton, MD
Aspirin is used in prenatal care to help prevent development of hypertensive (high blood pressure) disorders (conditions) of pregnancy, like preeclampsia and gestational hypertension. The purpose of this multi-year trial is to compare two commonly prescribed doses of aspirin. Participants are randomized into one of two groups and receive either 81mg or 162mg to take for the duration of their pregancy until delivery. They also complete a short postpartum questionnaire.
Research Coordinator:
Mounika Gopi
A Comparative Effectiveness Trial of Oral Metformin versus Injectable Insulin for the Treatment of Gestational Diabetes
Principal Investigators: Nasim Sobhani, MD
Gestational diabetes mellitus (GDM) is a common issue during pregnancy that can lead to health complications for both the mother and baby. The purpose of this study is to compare the two most commonly prescribed GDM medications, insulin and metformin. Participants will be randomized to receive either metformin or insulin and followed up for two years after giving birth. The study will assess various outcomes, including pregnancy complications, child health, and patient-reported experiences.
Research Coordinator:
Cyvanah Byrd-Eley
To learn more about study participation, email [email protected] or click navy blue button on the right.